ArticleGlobalization and health2025
Actor-network and stakeholder analysis in preventing health goods smuggling in Iran.
Article in Globalization and health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe prevention of health goods smuggling requires the involvement of stakeholders from various sectors, including the executive, judicial, and legislative bodies. This may increase numerous challenges in designing, formulating, implementing, and evaluating any corrective interventions. The aim of this study is therefore to identify and analyze the network of stakeholders and actors having a likely voice and part in preventing the smuggling of health goods (PSHG) in Iran.
methodWe conducted actor network analysis in three phases: actor identification, actor classification, and actor relationship analysis. The participants were selected using purposive sampling from the executive, judiciary, and legislature bodies. We categorized the qualitative data using thematic analysis, and analyzed quantitative data using matrix drawing and actor-network analysis, facilitated by Gephi (version 0.9.7) and Excel (2013) software.
resultsThe study identified 60 actors with different levels of status, power, interest, and awareness. The most powerful and supportive actors were the security and judicial institutions and the Central Headquarters to Combat the Smuggling of Goods and Currency (CHCSGC). Despite their significant influence, neither citizens nor the private sector showed a willingness to take steps toward preventing the smuggling of medical goods. Other actors had moderate or low levels of support and power in policies to prevent the smuggling of health goods. The Social Network Analysis (SNA) showed that the density of social networks was low, indicating a lack of cooperation and adequate interaction among those actors.
conclusionGiven the complex and multi-faceted nature of smuggling phenomenon, the policy makers and managers should take cognizance of the all actors’ diversity, roles and interactions. Subsequently, uncovering the reasons behind the players’ reluctance to participate, especially for such a critical issue, could strengthen the preventive actions towards smuggling, followed by a framework for meaningful stakeholder engagement, and appropriate support and incentive mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.